Preferred Label : gadobenic acid;

MeSH note : used in MR imaging of liver;

MeSH synonym : 3,6,9-triaza-12-oxa-3,6,9-tricarboxymethylene-10-carboxy-13-phenyltridecanoic acid, gadolinium; Gd-BOPTA;

MeSH hyponym : gadobenate dimeglumine; gadolinium-BOPTA-Dimeg; B-19036;

MeSH Related Number : gadobenic acid, dimeglumine salt; 113662-23-0 (gadobenic acid); 127000-20-8 (dimeglumine); 3Q6PPC19PO;

Registry Number MeSH : 113662-23-0;

Related CAS MeSH : 127000-20-8 (gadobenic acid, dimeglumine salt);

related registry number list (CISMeF) : 127000-20-8 (dimeglumine);

Is substance : O;

UNII : 15G12L5X8K;

InChIKey : MXZROTBGJUUXID-UHFFFAOYSA-K;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2869904/fr/multihance
2018
false
false
false
France
French
evaluation of the transparency committee
child
adolescent
gadobenic acid, dimeglumine salt
gadobenic acid
organometallic compounds
meglumine

---
https://www.has-sante.fr/portail/jcms/c_2869916/fr/multihance-acide-gadobenique
https://www.has-sante.fr/portail/jcms/c_2869916/fr/multihance
2018
false
false
false
France
contrast media
injections, intravenous
insurance, health, reimbursement
magnetic resonance angiography
magnetic resonance imaging
guidelines for drug use
gadobenic acid
evaluation of the transparency committee
gadobenic acid

---
https://ansm.sante.fr/informations-de-securite/produits-de-contraste-a-base-de-gadolinium-et-retention-de-gadolinium-dans-le-cerveau-et-dans-dautres-tissus-suspension-des-amm-de-lacide-gadopentetique-et-du-gadodiamide-utilises-en-intraveineux-restriction-de-lamm-de-lacide-gadobenique-a-li
2018
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
gadolinium
contrast media
cerebrum
gadobenic acid
gadolinium DTPA
injections, intravenous
injections, Intra-Articular
gadobenic acid
gadopentetic acid
gadodiamide
gadodiamide
organometallic compounds
meglumine
meglumine

---
http://www.has-sante.fr/portail/jcms/c_1779498/fr/multihance
2014
false
France
French
breast neoplasms
gadobenic acid
meglumine
contrast media
organometallic compounds
treatment outcome
pharmaceutical solutions
injections, intravenous
gadobenic acid
evaluation of the transparency committee
gadobenic acid, dimeglumine salt
magnetic resonance imaging
adult
insurance, health, reimbursement
Outcome Assessment, Health Care
breast neoplasms

---
http://www.has-sante.fr/portail/jcms/c_834663/multihance-gadobenate-de-dimeglumine-produit-de-contraste
http://www.has-sante.fr/portail/jcms/c_1234480/multihance
http://www.has-sante.fr/portail/jcms/c_810805/multihance
http://www.has-sante.fr/portail/jcms/c_538092/multihance
http://www.has-sante.fr/portail/jcms/c_399155/multihance-0-5-mmol/ml-solution-injectable-iv-flacons-de-5-ml-10-ml-15-ml-et-20-ml
http://www.has-sante.fr/portail/jcms/c_1648993/fr/multihance
http://www.has-sante.fr/portail/jcms/c_1648992/fr/multihance-18092013-avis-ct12719
2013
France
French
magnetic resonance angiography
gadobenic acid
meglumine
contrast media
organometallic compounds
treatment outcome
pharmaceutical solutions
injections, intravenous
gadobenic acid
evaluation of the transparency committee
gadobenic acid, dimeglumine salt
magnetic resonance imaging
adult
child
central nervous system diseases
liver neoplasms
vascular diseases
insurance, health, reimbursement
Outcome Assessment, Health Care
vascular diseases
central nervous system diseases
liver neoplasms

---
Nous contacter.
14/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.